Texas Doctor with Measles Praised as 'Extraordinary' Healer
April 20, 2025 - 14:51
A Texas doctor who has been actively treating children during a measles outbreak was recently featured in a video showing him with a visible measles rash on his face. This video surfaced just a week before Health Secretary Robert F. Kennedy Jr. visited the clinic and commended the doctor, calling him an “extraordinary” healer.
The doctor has been at the forefront of the measles outbreak, providing care to affected children while also facing scrutiny over his own health status. The situation raises concerns about the risks of contagion in medical settings, particularly when healthcare professionals are exposed to infectious diseases. Kennedy Jr.'s endorsement has sparked debate regarding the implications of praising a medical professional who is visibly ill while treating vulnerable patients.
As the outbreak continues, the medical community is closely monitoring the situation, emphasizing the importance of vaccination and public health measures to prevent further spread of the disease.
MORE NEWS
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...